Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Richard B. Aguilar

Richard B. Aguilar

Chief Clinical Officer, Cano Health Inc

Title: The Addition Of A Single Dose of Platelet Rich Plasma (PRP) After Sarapin Therapy For Treatment Of Chronic Knee Pain In Elderly Patients In A Primary Care Setting

Biography

Biography: Richard B. Aguilar

Abstract

The efficacy of PRP in Chronic Knee Pain (CKP) has not been confirmed  and usually requires up to 3 injections (1,2).  Recently, significant improvement in CKP was reported in a cohort of 95 elderly patients following the administration of 3 weekly intraarticular injections of low cost aqueous Sarapin (3). This study sought to explore the effect of adding a single intraarticular injection of PRP to this cohort after completing the initial series of 3 Sarapin injections.  A pain and functional limitation survey (a modified Lower Extremity Functional Scale (mLEFS)) was administered prior to initiating treatment (Entry Survey (ES)), one week After 3 Sarapin injections (AS) and then 30 (PRP30), 60 (PRP60), and 90 (PRP90) days after the single PRP injection. Higher scores denote a worse condition.